Switch View
© Globe Newswire
04.09.2025
ISIN: US4884452065
Zevra Therapeutics Inc
ZVRA
LISTED
NASDAQ
Zevra Therapeutics Presents Positive New Data Supporting Foundational Role of MIPLYFFA® (arimoclomol) for the Treatment of Niemann-Pick Disease Type C at the International Congress of Inborn Errors of Metabolism (ICIEM)
News Preview
New data from pre-specified analysis shows patients on concomitant miglustat who switched from placebo to MIPLYFFA experienced a decline in annual disease progression...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US67080T1088
Nuvectis Pharma Inc
NVCT
LISTED
NASDAQ
Nuvectis Pharma to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Fort Lee, NJ, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that senior management will particip...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US88322Q1085
TG Therapeutics Inc
TGTX
LISTED
NASDAQ
TG Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Fireside chat scheduled for Monday, September 8, 2025, at 10:30am ET Fireside chat scheduled for Monday, September 8, 2025, at 10:30am ET...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
04.09.2025
ISIN: US00534A1025
Invivyd Inc
IVVD
LISTED
NASDAQ
SPEAR Study Group to Present its Recommended Long COVID Antibody Study Design Featuring Invivyd’s VYD2311 At RECOVER-TLC Workshop September 9-10, 2025
News Preview
WALTHAM, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the SPEAR Study Group has issued their consensus recommendation for a clinical study design to evaluate the effects of monoclonal antibody (mAb) therapy on Long COVID. The recommendation will be presented for consideration to RECOVER-TLC, an NIH i...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
04.09.2025
ISIN: US12529R1077
C4 Therapeutics Inc
CCCC
LISTED
NASDAQ
C4 Therapeutics Highlights Recent Achievement in Biogen Collaboration
News Preview
Development Candidate Targeting IRAK4 Now Progressing Toward Clinical Development Development Candidate Targeting IRAK4 Now Progressing Toward Clinical Development...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: CA01559R1038
Algernon Pharmaceuticals Inc.
AGN
LISTED
CSE
Algernon Pharmaceuticals Announces Name Change to Algernon Health
News Preview
VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it is changing its name to Algernon Health....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US28658R1068
Climb Bio, Inc
CLYM
LISTED
NASDAQ
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025
News Preview
WELLESLEY HILLS, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced details for the CLYM116 webcast event, which is set for Monday, September 29, 2025, at 8:00 a.m. ET. Climb Bio’s management team will be joined by l...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US03843E1047
Aquestive Therapeutics Inc
AQST
LISTED
NASDAQ
Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™
News Preview
WARREN, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that the U.S. Food and Drug Administration (FDA) has info...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US74112D1019
Prestige Consumer Healthcare Inc
PBH
LISTED
NYSE
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
News Preview
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 4, 2025 at 12:45 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the “Investo...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: DK0060027142
ALK-Abelló A/S
ALK B
LISTED
CPH
ALK expands the Executive Leadership Team to include key commercial regions
News Preview
ALK (ALKB:DC / OMX: ALK B) today announced the decision to elevate its key commercial regions into the Executive Leadership Team (ELT) to further strengthen the execution of ALK’s strategy, Allergy+....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.09.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Lunai Bioworks Inc. Retains American Defense International
News Preview
Collaboration aims to apply Lunai Bioworks Inc. biomedical AI platform to accelerate countermeasure development for chemical agents like sarin and other biothreats LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 4, 2025 / Lunai Bioworks Inc. DBA Renovaro Inc. (NASDAQ:RENB), Lunai Bioworks Inc. is an AI-powered tech bio company pioneering safe...
Themefolio
Profiler
Peergroup
© EQS Newswire
04.09.2025
ISIN: DE000A11QVV0
Heidelberg Pharma AG
HPHA
LISTED
XETR
Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2025
News Preview
PRESS RELEASE
Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2025
Ladenburg, Germany, 4 September 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage company developing innovative Antibody Drug Conjugates (ADCs), today announces that new data from ......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
04.09.2025
ISIN: DE000A11QVV0
Heidelberg Pharma AG
HPHA
LISTED
XETR
Heidelberg Pharma gibt die Präsentation neuer klinischer Daten des führenden ATAC-Kandidaten HDP-101 auf der International Myeloma Society-Jahrestagung 2025 bekannt
News Preview
PRESSEMITTEILUNG
Heidelberg Pharma gibt die Präsentation neuer klinischer Daten des führenden ATAC-Kandidaten HDP-101 auf der International Myeloma Society-Jahrestagung 2025 bekannt
Ladenburg, 4. September 2025 – Die Heidelberg Pharma AG (FWB: HPHA), ein klinischer Entwickler von innovativen Antikörper-Wirkstoff-Konjugaten (Antibody Drug Conjugat......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.09.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC PINK:MDCE) Advances Skin Cancer Prevention with AI Mole Tracking System
News Preview
MESA, ARIZONA / ACCESS Newswire / September 4, 2025 / Medical Care Technologies Inc. (OTC PINK: MDCE) is proud to announce the development of its AI-driven Mole Tracking System, a breakthrough dermatological monitoring tool for early skin cancer detection.The system uses full-body lesion indexing, 3D body-mapping algorithms, and temporal skin-chang...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.09.2025
ISIN: US45840Y2037
Interactive Strength, Inc.
TRNR
LISTED
NASDAQ
Interactive Strength Inc. (Nasdaq:TRNR) Investment Drives Sportstech's Accelerating Growth, with 45% Revenue Growth in August
News Preview
Current FX rates indicate that the LTM August 2025 Revenue would be approximately $58M with $6M in EBITDASportstech announced May to August 2025 revenue growth of 20% YOYTRNR Investment in Sportstech working capital is accelerating growth for the pending acquisition, with full-year 2025 Revenue growth expected to exceed 30%Strong Business Momentum...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.09.2025
ISIN: US03835L2079
Aptevo Therapeutics Inc.
APVO
LISTED
NASDAQ
Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules
News Preview
New candidates, APVO452 and APVO451, harness proprietary ADAPTIR-FLEXTM design to target prostate and multiple solid tumor cancers by simultaneously engaging tumor antigens, T cells, and immunosuppressive cellsMipletamig-driven clinical validation of the CRIS-7-derived CD3 binding domain underpins Aptevo's introduction of new, trispecific CD3-direc...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.09.2025
ISIN: US88066N3035
Tenon Medical, Inc.
TNON
LISTED
NASDAQ
Tenon(R) Medical Announces Second Peer-Reviewed Catamaran Mainsail(TM) Study Publication, Underscores Robust and Sustainable Clinical Outcomes Out to 12 Months
News Preview
~ Clinically Significant Patient Outcomes Demonstrate Improvements in Pain (VAS) and Disability (ODI), Along with High Patient Satisfaction and Safety Profile at 12-Month Analysis ~~ 83% of Patients Reaching 12 Month Radiographic CT Follow-up Showed Unequivocal Evidence of Fusion with Bridging Bone Across the SI Joint as Identified by an Independen...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.09.2025
ISIN: CA00143Y1034
AI-ML Innovations Inc.
AIML
LISTED
CSE
AIML Announces Proposed Private Placement
News Preview
VANCOUVER, BC / ACCESS Newswire / September 4, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that it intends to complete a non-brokered private placement offering of up to 31,000,000 units ("Units") at a price of $0.05 per Unit for gross proceeds of up...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: CA75103L1013
Rakovina Therapeutics Inc.
RKV
LISTED
TSX
Rakovina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, today announced that Executive Chairman, Jeffrey Bacha, and Chief Financial Officer, Dr. David Kideckel, will a...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: CH0329023102
AC Immune SA
ACIU
LISTED
NASDAQ
AC Immune Sharpens Pipeline Focus with Operational Efficiencies Extending Cash Runway
News Preview
AC Immune Sharpens Pipeline Focus with Operational Efficiencies Extending Cash Runway...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.09.2025
ISIN: US04537Y1091
Aspira Women's Health Inc.
AWH
LISTED
NASDAQ
Aspira Women’s Health Appoints New Chief Financial Officer
News Preview
New Executive Brings 20+ Years of Accounting,Capital Markets & Biotechnology Experience AUSTIN, TX / ACCESS Newswire / September 4, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (QTCQB:AWHL), an AI enhanced bio-analytical based women's health company focused on delivering the leading tools critical to gynecol...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development’s portfolio company Umecrine Cognition publishes data showing sustained effect of golexanolone in a Parkinson’s disease model
News Preview
STOCKHOLM – September 4, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has presented data showing that its drug candidate golexanolone provides sustained reversal of neuroinflammation in a Parkinson's disease model. The data, published in the scientific journal Frontiers in Im...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Roche receives CE mark for Contivue, its Port Delivery Platform containing Susvimo, for neovascular age-related macular degeneration (nAMD)
News Preview
Basel, 04 September 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received the EU CE mark for its Port Delivery Platform containing Susvimo, which will now be known as Contivue® in the EU.6 The device comprises the eye implant through which Susvimo is delivered, and four ancillary devices to initially fill, insert, refill, a...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US03675P1021
Anteris Technologies Global Corp.
AVR
LISTED
NASDAQ
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
News Preview
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US1167941087
Bruker Corp
BRKR
LISTED
NASDAQ
Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock
News Preview
Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced the pricing of its previously announced public offering of $600.0 million of 6.375% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock”). Bruker has granted the underwriters a 30-day option to purchase up to an additiona...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis
News Preview
Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: CH0325814116
Kuros Biosciences AG
KURN
LISTED
SIX
Kuros Biosciences announces changes in the Board of Directors
News Preview
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis
News Preview
Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Join Lantheus Holdings, Inc. Fraud Investigation with the Schall Law Firm
News Preview
LOS ANGELES, Sept. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ: LNTH) for violations of the securities laws....
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: JP3160400002
Eisai Co Ltd
45230
LISTED
XJPX
Eisai to Present Latest Data on Lemborexant and Novel Orexin Receptor Agonist E2086 at The World Sleep 2025
News Preview
TOKYO, Sept. 3, 2025 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the company will deliver a total of 11 presentations, including clinical data on the selective orexin 2 receptor agonist (OX2R) E2086 and the latest findings on its in-house discovered orexin receptor antagonist lemborexant (...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US28036F1057
Edgewise Therapeutics Inc
EWTX
LISTED
NASDAQ
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
News Preview
BOULDER, Colo., Sept. 3, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions, today announced that on August 29, 2025, Edgewise granted inducement stock options to pur...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: JP3801300009
Phc Holdings Corp.
65230
LISTED
XJPX
Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics
News Preview
PHC Holdings Corporation (President, Representative Director and CEO: Kyoko Deguchi, TSE: 6523) and its subsidiary Ascensia Diabetes Care, a global diabetes care company, today announced that Ascensia has signed a memorandum of understanding to transfer the commercial operations for Eversense® Continuous Glucose Monitoring (CGM) systems to Eversen...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US6402683063
Nektar Therapeutics
NKTR
LISTED
NASDAQ
Nektar Therapeutics to Participate in Two Investor Conferences in September
News Preview
SAN FRANCISCO, Sept. 3, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its participation in the H.C. Wainwright 27th Annual Global Investment Conference being held September 8-10, 2025 in New York City and the Stifel Virtual Immunology and Inflammation Forum being held September 15-16,...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US0465131078
Atara Biotherapeutics, Inc.
ATRA
LISTED
NASDAQ
Atara Biotherapeutics Announces Changes to Its Board of Directors
News Preview
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Greg Ciongoli will assume the role of Chair of the Board of Directors.
Greg Ciongoli is t...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: VGG1110E1079
Biohaven Ltd
BHVN
LISTED
NYSE
Biohaven Ltd. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BHVN
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Biohaven Ltd. (“Biohaven” or “the Company”) (NYSE: BHVN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of BHVN during the class...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Centene Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CNC
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Centene Corporation (“Centene” or “the Company”) (NYSE: CNC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of CNC during the cla...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: CA1380357048
Canopy Growth Corp
CGC
LISTED
NASDAQ
Leading Independent Proxy Advisory Firm ISS Recommends Canopy Growth Shareholders Vote FOR All Resolutions
News Preview
Canopy Growth Corporation (TSX: WEED) (NASDAQ:CGC) ("Canopy Growth" or the "Company") is pleased to announce that leading independent proxy advisory firm Institutional Shareholder Services Inc. (“ISS”) has recommended Canopy Growth shareholders (“Shareholders”) vote “FOR” each of the resolutions to be approved at the upcoming Annual General and Sp...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
News Preview
Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 14th to review third-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Darren Snellgrove, Vice President, Investor Relations will ho...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Replimune (REPL) Faces Investor Lawsuit After FDA Blocks Cancer Drug Approval - Hagens Berman
News Preview
SAN FRANCISCO, Sept. 3, 2025 /PRNewswire/ -- Replimune Group Inc. (NASDAQ: REPL) is under fire from investors following a dramatic regulatory setback that sent its stock into freefall. A newly filed securities class action accuses the biotech firm and its leadership of concealing critical risks tied to its flagship cancer therapy, RP1, and overst...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 128,000 shares of Astria’s common stock on September 2, 2025 under Astria’s 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is use...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US29446K1060
Equillium Inc
EQ
LISTED
NASDAQ
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that on August 29, 2025, the Compensation Committee of Equillium’s Board of Directors granted inducement awards consisting of nonstatutory stock options to purchase an aggregate of 150,000 shares...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US71535D1063
Personalis, Inc.
PSNL
LISTED
NASDAQ
Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing
News Preview
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca phase 3 clinical trial in lung cancer (NeoADAURA). The findings demonstrate that Personalis’ highly sensitive molecular residual disease (MRD) test, NeXT Personal®, is a strong predictor of outcomes in patients with stage I...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US4364401012
Hologic Inc
HOLX
LISTED
NASDAQ
Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 23rd Annual Morgan Stanley Global Healthcare Conference in New York at 10:45 a.m. Eastern Time on Tuesday, September 9th.
The fireside chat presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US92790C1045
Viridian Therapeutics Inc
VRDN
LISTED
NASDAQ
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the Compensation Committee of the company’s Board of Directors, made up entirely of independent directors, approved the grant of non-qu...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus to Participate in Morgan Stanley’s 23rd Annual Global Healthcare Conference
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in Morgan Stanley’s 23rd Annual Global Healthcare Conference. The conference will take place September 8-10 in New York City. Eric Lefkofsky, Founder and CEO of Tempus, and Jim Rogers, Chief Financial Offi...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US03940C1009
Arcellx Inc
ACLX
LISTED
NASDAQ
Arcellx to Participate at the 2025 Morgan Stanley Global Healthcare Conference
News Preview
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in a fireside chat at the 2025 Morgan Stanley Global Healthcare Conference on Wednesday, September 10, 2025 at 1...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US81727U1051
Senseonics Holdings Inc
SENS
LISTED
XASE
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365
News Preview
CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US83601L1026
Sotera Health Co
SHC
LISTED
NASDAQ
Sotera Health Announces Secondary Offering of Common Stock
News Preview
CLEVELAND, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 20,000,000 shares of its common stock, par value $0.01 per share. All 20,000,000 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) a...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US9183851057
vTv Therapeutics Inc.
VTVT
LISTED
NASDAQ
UPDATE -- vTv Therapeutics to Participate in Upcoming September Investor Conferences
News Preview
HIGH POINT, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes (T1D), today announced that management will part...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between M...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US04301G1022
Artelo Biosciences, Inc.
ARTL
LISTED
NASDAQ
Artelo Biosciences Announces Proposed Underwritten Public Offering
News Preview
SOLANA BEACH, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today announced it has commenced an underwritten public offeri...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US05337M1045
Avadel Pharmaceuticals plc
AVDL
LISTED
NASDAQ
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd
News Preview
– Expands Avadel’s pipeline with salt-free, artificial sweetener-free, once-at-bedtime oxybate for treatment of narcolepsy and idiopathic hypersomnia –...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US62855J1043
Myriad Genetics Inc
MYGN
LISTED
NASDAQ
New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression
News Preview
Results published in the Journal of Clinical Psychopharmacology Results published in the Journal of Clinical Psychopharmacology...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US68062P1066
Olema Pharmaceuticals, Inc.
OLMA
LISTED
NASDAQ
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN FRANCISCO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to four new em...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US70805E1091
Pennant Group Inc
PNTG
LISTED
NASDAQ
Pennant Announces Home Health Acquisition in Wyoming
News Preview
EAGLE, Idaho, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that effective September 1, 2025, it has acquired a premier home health agency and outpatient therapy operation in Wyoming. Both...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Châtillon, France, September 3, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US78397T2024
SAB Biotherapeutics, Inc.
SABS
LISTED
NASDAQ
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes
News Preview
MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing a multi-specific human anti-thymocyte immunoglobulin (hIgG) for delaying the onset and progression of autoimmune type 1 diabetes (T1D),...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US01626L1052
Aligos Therapeutics, Inc.
ALGS
LISTED
NASDAQ
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
News Preview
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced six presentations, including three oral presentations, at the 2025 International HB...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Alto Neuroscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ANRO
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Alto Neuroscience, Inc. (“Alto” or “the Company”) (NYSE: ANRO) for violations of the federal securities laws.
Shareholders who purchased shares of Alto during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment...
Themefolio
Profiler
Peergroup
© Newsfile
03.09.2025
ISIN: US85858U3059
Stem Holdings Inc.
STEM
LISTED
CSE
CSE Bulletin: Delist - Stem Holdings Inc. (STEM)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 3 septembre/September 2025) - The common shares of Stem Holdings Inc. will be delisted from the CSE at market close today, September 3, 2025. Stem Holdings Inc. is currently suspended. See Bulletin 2024-0302. _________________________________ Les actions ordinaires de S...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
